Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Beijing Cancer Hospital"
Count: 358
Selected: 0
NCT IDTitle
NCT06229041Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)
NCT03389438Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma
NCT05833802Computation Prediction of Drug Response Based on Omics Data
NCT0305158118F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
NCT03051568Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma
NCT0305155518F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma
NCT03051542Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma
NCT06081777Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer
NCT02942043Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
NCT03199989Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)
NCT03708978Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography
NCT0500037268Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy
NCT0459667068Ga-ICAM-1pep PET/CT in Cancer Patients
NCT02159339DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma
NCT03031444Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis
NCT02878057Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)
NCT01661218Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients
NCT02464215Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric Cancer
NCT03448549SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
NCT04303130Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC
NCT02500810Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients
NCT03286920Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT03528421Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients
NCT03454919Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations
NCT06306755Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer
NCT06360042Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC
NCT04224298Preliminary Study on Eye Features of Patients With Malignant Tumors
NCT04542837The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
NCT06313957A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
NCT06256315Hyper-ERAS Program for Highly Selective Colorectal Cancer Patients
NCT05436093CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
NCT05321316Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
NCT04883970CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors
NCT04693169[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients
NCT04629326PD-L1 Targeting Molecular Imaging of Solid Tumors
NCT04560725PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer
NCT04304066Research for the Molecular Imaging of the PD-L1 Targeting Tracer
NCT05229029RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy
NCT06211114Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma
NCT06209099Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer
NCT06203119Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe
NCT05590221Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
NCT06184841HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma
NCT05322512Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
NCT06141265Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab
NCT04547309Research for the Molecular Imaging of the HER2 Targeting Tracer
NCT05961514the Beijing Randomized Study Of Prostate Cancer Screening
NCT06099821KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
NCT05985109KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
NCT06004713Registry Study in MSI/dMMR Solid Tumors